Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

In trading today, shares of Nervgen Pharma Corp opened at $2.84 and closed at $2.82. prices ranged from a low of $2.82 to a high of $2.86.

Shares eased -1.05% from the previous day's close of $2.85.

Today across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 25,300 on 36 total trades, with an average volume of 37,447 over the last 5 days.

The TSX-V overall saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 67.86 percent, while they have advanced 4.44% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $199.29 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..